14478 results for "PLOS+ONE+Pennsylvania+German+ACS+language+code+pdc+open+access+study"

in 16.70 milliseconds.

• Small molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma (RNAseq dataset)

  Study EGAS00001004748

• Characterization of T cell tumor infiltration in brain metastases through the analysis of the cerebrospinal fluid

  Study EGAS00001004751

• CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas

  Study EGAS00001007577

• Single cell characterization of arrested B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia

  Study EGAS00001004374

• RNA sequencing of subchondral bone from patients that underwent a joint replacement surgery due to osteoarthritis.

  Study EGAS00001004476

• Colorectal cancer cells possess an equipotent capacity to enter a developmental pausing-like state to survive chemotherapy

  Study EGAS00001004773

• Clonal dynamics of normal hepatocyte expansions in homeostatic human livers and their association with the biliary epithelium

  Study EGAS00001005539

• Single-cell RNA sequencing of a PBMC sample collected from a male with 45,X/48,XYYY karyotype

  Study EGAS00001005697

• Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

  Study EGAS00001005791

• Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

  Study EGAS00001006134

• Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial

  Study EGAS00001006342

• Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient

  Study EGAS00001006530

• Targeted exome DNA sequencing analysis of POETIC Good/Poor Responders to aromatase inhibitors based on change in Ki67

  Study EGAS00001007303

• Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

  Study EGAS00001007430

• Therapeutic vulnerabilities in CCA from different etiologies identified using integrative multi-omics enhancer activity profiling

  Study EGAS00001007309

• RNA-seq of lung neuroendocrine tumors

  RNA-seq of lung neuroendocrine tumors

  Study EGAS50000000058

• A cycling, progenitor-like cell population at the root of atypical teratoid rhabdoid tumor subtype differentiation trajectories

  Study EGAS00001008123

• Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients

  Study EGAS00001005599

• Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

  Study EGAS00001004615

• Transcriptome Sequencing Data of High Grade Serous Ovarian Cancer

  Study EGAS00001004714

• Evolution_of_the_cancer_epigenome_in_myeloproliferative_neoplasms_2

  Whole genome sequencing and bisulphite sequencing of haematopoietic colonies

  Study EGAS00001002372

• ICR MOPOPGEN UK exome control series

  ICR MOPOPGEN UK exome control series

  Study EGAS00001001667

• Imputation-Based Meta-Analysis of Severe Malaria in Three African Populations

  To be done

  Study EGAS00001000807

• An approach for evaluating the effects of dietary fiber polysaccharides on the human gut microbiome and plasma proteome

  Study EGAS00001005330

• scRNA mCRC PDO

  scRNA of five mCRC organoids in basal conditions

  Study EGAS00001006214

• Engineered_cartilage__deriving_design_principles_from_human_developmental_pathways

  Engineered cartilage: deriving design principles from human developmental pathways

  Study EGAS00001006224

• Plasma DNA profile in DNASE1L3 deficiency

  Plasma DNA profile in DNASE1L3 deficiency

  Study EGAS00001004342

• Engineered_cartilage__deriving_design_principles_from_human_developmental_pathways

  Engineered cartilage: deriving design principles from human developmental pathways

  Study EGAS00001006443

• Summary statistics for cervical cancer GWAS

  Summary statistics from GWAS meta-analysis of cervical cancer

  Dataset EGAD00001004361

• CPC-GENE Prostate Cancer Heterogeneity Study

  Raw sequence data, fastq format

  Dataset EGAD00001002885

• WGS data for NRF2 study

  WGS data for cell lines and clinical samples

  Dataset EGAD00001002244

• Summary statistics

  Summary statistics Korean PD (n=410) vs. Korean Healthy Control (n=200)

  Dataset EGAD00001009775

• Metastatic_Prostate_Follow_Up

  Validation/deeper sequencing for metastatic prostate cancer samples

  Study EGAS00001000730

• Metastatic_Prostate_Follow_Up_2

  Validation/deeper sequencing for metastatic prostate cancer samples

  Study EGAS00001000756

• NSAID-LIV

  1000G Phase 3 Imputed cases and controls from NSAID-induced PUD study

  Dataset EGAD00010001422

• HGP-U-1

  Himalayan population genetic study raw data (Himalaya)

  Dataset EGAD00010001472

• EXCEED Study HRC imputation

  EXCEED samples imputed to HRC reference panel using Michigan Imputation server

  Dataset EGAD00010001685

• DAC for the study molecular biomarkers associated with the diagnosis and severity of genetic and diseases from PAIDI-BIO354 GENYO-UGR)

  Dac EGAC00001003090

• Whole Exome Sequencing of Bipolar cases and matched controls performed at the Broad Institute on a cohort from Germany

  Study EGAS00001005858

• resistance to FGFR inhibitor from RNA sequencing

  WTS performed on tissues from resistant patients

  Study EGAS50000000306

• The genomic landscape of large and small tumors in early-onset prostate cancer patients

  Study EGAS00001000383

• Novel de novo pathogenic variant in the GNAI1 as a cause of severe disorders of intellectual development with autistic features

  Study EGAS00001005346

• Somatic mutations in healthy and leukemic blood progenitors reveal evolutionary mechanisms underlying childhood leukemia and differential patient outcome

  Study EGAS00001004593

• Gene expression profiles of disseminated breast cancer cells

  Study EGAS00001004597

• Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

  Study EGAS00001004975

• Novel de novo pathogenic variant in the GNAI1 as a cause of severe disorders of intellectual development with autistic features

  Study EGAS00001005355

• RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics

  Study EGAS00001005368

• Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA

  Study EGAS00001005740

• Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.

  Study EGAS00001006364

• transcriptome analysis of NK cells sorted from PBMCs at baseline and after addition of a T cell dependent bispecific antibody (TDB)

  Study EGAS00001006914